Islet Cell Transplantation - Current and Future Approaches
We are very pleased to announce the next interactive, online, webinar, ‘virtual classroom’ teaching modules from the Education Committee of The Transplantation Society.
This program is designed as an advanced curriculum in Renal Transplantation to be made available to members of TTS world wide free of charge. This curriculum will be administered through online webinars from June 2015 at monthly intervals. Experts on the key topics in the field of transplantation will present the interactive webinars. The courses will be designed incorporating the new learning and teaching techniques as described in the TTS Distinguished Educator course. The target audience for this series is doctors and trainees, who have a keen interest in advancing their knowledge in renal transplantation. This will enable them to practice the state-of-the--art medicine anywhere in the world. This series will be CME accredited and those who complete the entire series will be awarded the TTS Certificate in Advanced Renal Transplantation.
Nithya KrishnanCourse Co-Director
Consultant Transplant Nephrologist
University Hospital Coventry &
Warwickshire NHS Trust
Coventry, United Kingdom
Medhat AskarCourse Co-Director
Professor, Department of Pathology and Laboratory Medicine
Texas A&M Health Science Center College of Medicine & Director of Transplant Immunology
Baylor University Medical Center, Dallas, TX, USA
TUESDAY, OCTOBER 04, 2016 - 11AM MONTREAL TIME (9AM EDMONTON)
ISLET CELL TRANSPLANTATION - CURRENT AND FUTURE APPROACHES
Dr. AM James Shapiro MD, PhD
Professor Peter G. Stock, MD
The online certificate site will be available the end of the day October 4, 2016 through December 4, 2016. After that date, the site will be removed and certificates will no longer be available. If you need a CME certificate, you must complete the evaluation and certificate process prior to that date; otherwise you will forfeit your credit for the course.
James Shapiro holds the Canada Research Chair in Transplantation Surgery and Regenerative Medicine. He directs the islet transplant program in Edmonton. He was the lead investigator on the famous “Edmonton Protocol” cell transplant treatment for diabetes. This year, his team began first in human trials with embryonic stem cell derived insulin producing cells transplanted in an immunoisolation device.
- Understand current studies and programs in clinical islet cell transplantation.
- Discuss progress in transition from research to more routine clinical care for selected patients with TIDM
- Discuss future potential approaches, including stem cell transplantation and tolerance, that could facilitate more broad application of cell transplant and regeneration treatments in diabetes.
Acknowledgement of Commercial Support, Satisfactory Completion, Accreditation Statement, Credit Designation Statement, Note for CME Regarding Europeans, Note for CME Regarding Canadians, Program Learning Objectives, Faculty Disclosure
- 1.4GHz Intel® Pentium® 4 or faster processor (or equivalent) for Microsoft® Windows 7, Windows 8 or Windows 8.1
- Windows 8.1 (32-bit/64-bit), Windows 8 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
- 512MB of RAM (1GB recommended) for Windows 7 or Windows 8
- Microsoft Internet Explorer 8 or later; Mozilla Firefox; Google Chrome
- Adobe® Flash® Player 11.2+
- 1.83GHz Intel Core™ Duo or faster processor
- 512MB of RAM (1GB recommended)
- Mac OS X 10.8, 10.9, 10.10
- Mozilla Firefox; Apple Safari; Google Chrome
- Adobe Flash Player 11.2+
- Ubuntu 14.04; Red Hat Enterprise Linux 6; OpenSuSE 13.1
- No Add-in support for Linux. Users on Linux can attend meetings in the browser.
- Google Chrome
- Adobe Flash Player 11.2+
- Apple supported devices: iPhone 5S, iPhone 5, iPhone 4S, iPad with Retina display, iPad 3, iPad 2, iPad mini, and iPod touch (4th & 5th generations)
- Apple supported OS versions summary: iOS 6 and higher
- Android supported devices: Motorola DROID RAZR MAXX, Motorola Atrix, Motorola Xoom, Samsung Galaxy Tab 2 10.1, Samsung Galaxy S3 & S4, Nexus 7 tablet
- Android supported OS versions summary: 2.3.4 and higher
If you have never attended a Connect Pro meeting before:
Test your connection: http://dlp.adobeconnect.com/common/help/en/support/meeting_test.htmGet a quick overview: http://www.adobe.com/go/connectpro_overview
No commercial support was received for this enduring material activity.
Participants must complete pass the posttest with 80% or better and complete an evaluation form in order to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available.
Accreditation StatementThe Transplantation Society (TTS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation StatementThe Transplantation Society designates this enduring material activity for 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note for CME regarding Europeans
Mutual recognition of credits between the American Medical Association and the UEMS-European Accreditation Council for CME. See the link below for more information.
Note for CME regarding Canadians
See link below for the AMA agreement with the Royal College of Physicians and Surgeons of Canada regarding CME credit conversion.
Program Learning Objectives
- Identify, explain, analyze the key clinical and physiological concepts of kidney transplantation
- Be able to relate and apply the key concepts of kidney transplantation in the day-to-day clinical practice.
- Employ a systematic approach in responding to diverse clinical scenarios related to kidney transplantation.
- Formulate appropriate management plans for clinical scenarios kidney transplantation
- Develop and modify these skills to be able to contribute to the education and professional development of junior colleagues.
All faculty participating in the continuing medical education programs sponsored by The Transplantation Society are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s).We acknowledge the potential presence of limitations on information, including, but not limited to: data that represents ongoing research; interim analysis; preliminary data; unsupported opinion; or approaches to care that, while supported by some research studies, do not represent the only opinion or approach to care supported by research.
Financial Relationship Key
S-Speaker ’s Bureau
N-Nothing to disclose
R1-Restricted to Best Available Evidence & ACCME content validation statement
R2-Removed/Altered Financial Relationship
R4-Peer Review with 2nd method of resolution
The list below includes all individuals in control of content for this CME activity
|Role||Last Name||First Name||Disclosure||Resolution|
- Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343(4):230-238
- Hering BJ, Clarke WR, Bridges ND, Eggerman TL, Alejandro R, Bellin MD, Chaloner K, Czaniecki CW, Goldstein JS, Hunsicker LG, Kaufman DB, Korsgren O, Larsen CP, Luo X, Markmann JF, Naji A, Oberholzer J, Posselt AM, Rickels MR, Ricordi C, Robien MA, Senior PA, Shapiro AMJ, Stock PG, Turgeon NA for the Clinical Islet Transplantation Consortium. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care 39(7):1230-1240.
The Transplantation Society (TTS) respects the privacy of visitors to its website. TTS strongly believes that our visitors must be assured that information provided online is used responsibly and appropriately. To protect online privacy, the TTS has implemented the following policy.
NOTE: THIS POLICY APPLIES ONLY TO ONLINE COLLECTION OF INFORMATION.
- Information We Collect and How We Use It
- TTS collects two types of information about you when you visit our website: personal information (including, by way of example only, your name, address, telephone number, e-mail address, demographic information and credit card information) and non-personal, aggregate information (such as information regarding the pages on our site that you have visited and your IP address).
- Personally Identifiable Information:
- TTS does not collect personally identifiable information about you unless you choose to provide it. Personal information is collected through membership application and inquiry processes and through other services or procedures that the TTS may implement from time to time. You are not required to submit any personally identifiable information in order to access information in the public areas of our website.
- To gain access to membership and other personalized features on the TTS website, users are asked to register and provide limited personal information. This information is submitted voluntarily. If you do not wish for us to have your personal information, please do not provide it.
TTS uses information voluntarily submitted by visitors in the following ways:
- TTS Services and Products.
- Generally, TTS uses data collected to improve its own web content; to identify popular areas of the website; to respond to visitor and member needs, interests and preferences and to develop new products and services.
- Credit Card Information:
- TTS does not disclose credit card information provided by its members and customers except to third parties that assist with processing credit card purchases. When and customers choose to pay by using their credit cards, TTS submits the information needed to obtain payment to the appropriate clearinghouse. The credit card numbers are not stored on our servers.
- Non-Personally Identifiable Information:
- TTS collects non-personally identifiable, aggregate information from visitors to our website. This non-personally identifiable information includes but is not limited to the number of hits per page, cookies, referrers, IP address, or other ‘environmental’ variables. The TTSd oes not link non-personally identifiable information with personally identifiable information. Aggregate data are only used for internal and marketing purposes and do not provide any personally identifiable information.
- Notification of Changes:
- Choices Available to the User:
- TTS provides the following choices regarding the use of your information:
- You may choose not to provide us with any personal information.
- You may set your browser to not accept cookies, or to warn you when a cookie is being placed on your computer. If you choose not to accept cookies, however, your ability to navigate this web site may be hindered.
- You understand and agree that “perfect” security does not exist anywhere, including on the Internet. When you send your credit card information to us over our website, we encrypt this information between your computer and our server. Other information you send to this site, including email messages, will not be encrypted unless we advise you otherwise. The TTS website is protected by a firewall and monitored for security.
Third Party Links:
- This web site may contain links to other sites. PLEASE BE AWARE THAT WE ARE NOT RESPONSIBLE FOR THE CONTENT OR PRACTICES OF ANY OTHER SITES.
We encourage our users to read the privacy statements of each and every web site that they visit. This privacy statement applies solely to the TTS website.
- The TTS website is designed to provide users with educational activities, scientific and meeting information, current societal news, public policy information and other needs for transplant professionals. This information is not the same as retaining experts in these fields for advice. Nothing contained in this website is to be considered as the rendering of legal, medical, professional or other advice for specific cases, and users are responsible for obtaining such advice from their own physicians. The information contained on this site is intended for educational, background and informational purposes only.
February 2, 2013
The Transplantation Society 2016